NORTHEASTERN UNIVERSITY
Mission Statement
The Cystic Fibrosis Foundation raises money to fund research and also to improve the quality of life for victims of the disease. Over one million dollars has been raised to date for Cystic Fibrosis through Delta Phi Epsilon. The Foundation supports the advancement of medical science by funding its own network of 14 research centers in North America. It also invests in research centers at leading universities and medical schools. By applying state-of-the-art science to targeted research opportunities, these centers have brought us close to a cure through individual research studies and research training programs. The Foundation also finances more than 112 Cystic Fibrosis care centers nationwide which provide high-quality care for those with CF. These centers, located at teaching and community hospitals, offer comprehensive diagnosis and counseling for people with CF and their families. Professional education and training are offered at both research and care centers on a year-round basis. As an organization that supports The Cystic Fibrosis Foundation, we host annual events and fundraisers and bring Norhteastern and it's Fraternity & Sorority Life together to help in the efforts to raise money and awareness.
Financial Overview — FY 2023
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
90.0% | 87.4% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.4% | 10.5% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
1.7% | 1.3% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
15312.7% | 4415.8% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
18.1 mo | 20.3 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
37.7% | 27.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
84.5% | 84.6% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
8.1% | -2.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
14.6% | 5.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.9% | 1.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2586.2M | $2460.5M | $3720.5M | 90.0% | 22569 |
| 2022 | $2393.4M | $2146.9M | $3471.3M | 92.0% | 20377 |
| 2021 | $2060.2M | $1846.6M | N/A | — | 18081 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.